Revenue (Tables)

12 Months Ended

Sep. 27, 2025

The following tables provide revenue from contracts with customers by business and geographic region on a disaggregated basis:


		Years Ended
		September 27, 2025						September 28, 2024						September 30, 2023
Business (in millions)		United States		Intl.		Total		United States		Intl.		Total		United States		Intl.		Total
Diagnostics:
	Cytology & Perinatal	$	296.1	$	192.5	$	488.6	$	283.3	$	195.9	$	479.2	$	297.4	$	183.2	$	480.6
	Molecular Diagnostics	1,028.4		282.0		1,310.4		999.1		273.4		1,272.5		1,061.0		300.7		1,361.7
	Blood Screening	28.2		—		28.2		30.3		—		30.3		37.8		—		37.8
Total		1,352.7		474.5		1,827.2		1,312.7		469.3		1,782.0		1,396.2		483.9		1,880.1

Breast Health:
	Breast Imaging	860.2		249.3		1,109.5		932.9		277.8		1,210.7		884.0		260.2		1,144.2
	Interventional Breast Solutions	282.1		92.5		374.6		244.6		67.6		312.2		232.6		55.9		288.5

Total		1,142.3		341.8		1,484.1		1,177.5		345.4		1,522.9		1,116.6		316.1		1,432.7

GYN Surgical		490.4		189.4		679.8		482.5		158.8		641.3		475.3		128.9		604.2

Skeletal Health		62.5		46.9		109.4		51.4		32.7		84.1		69.9		43.5		113.4


Total		$	3,047.9	$	1,052.6	$	4,100.5	$	3,024.1	$	1,006.2	$	4,030.3	$	3,058.0	$	972.4	$	4,030.4


	Years Ended
Geographic Regions (in millions)		September 27, 2025		September 28, 2024		September 30, 2023
United States		$	3,047.9	$	3,024.1	$	3,058.0
Europe		591.0		532.7		520.3
Asia-Pacific		243.3		259.6		255.7
Rest of World		218.3		213.9		196.4
		$	4,100.5	$	4,030.3	$	4,030.4

The following table provides revenue recognized by source:


	Years Ended
Revenue by type (in millions)		September 27, 2025		September 28, 2024		September 30, 2023
Disposables		$	2,617.7	$	2,490.2	$	2,539.4
Capital equipment, components and software		638.4		764.9		740.5
Service		825.5		758.2		730.5
Other		18.9		17.0		20.0
		$	4,100.5	$	4,030.3	$	4,030.4